Materials Today Nano,
Journal Year:
2024,
Volume and Issue:
26, P. 100483 - 100483
Published: May 21, 2024
Intracerebral
hemorrhage
(ICH)
is
a
common
cerebrovascular
disorder.
There
still
high
risk
of
severe
neurological
deficits
even
when
patients
survive
ICH.
The
application
new
treatment
techniques
can
reduce
mortality,
but
reversing
damage
caused
by
ICH
remains
challenging.
Although
cell-based
therapies
have
shown
promise
in
treating
cerebral
hemorrhage,
recurring
challenges
are
premature
apoptosis
transplanted
cells
accompanied
insufficient
numbers
and
lack
engraftment
the
target
tissue,
thus
limiting
therapeutic
efficacy.
Here,
we
show
that
hypoxic
preconditioning
combined
with
three-dimensional
(3D)
dynamically
cultured
gingival
lamina
propria-derived
MSCs
(GMSCs)
significantly
improves
cell
viability,
anti-apoptosis
ability,
efficacy
compared
traditional
monolayers.
Hypoxia-preconditioned
3D-GMSCs
also
exhibit
notable
neuroprotective
promote
extracellular
vesicles
(EVs)
biogenesis
potential
as
evidenced
transwell
vitro
intervention
experiments
RNA-seq;
further
confirmed
characterization
analysis
EVs.
Furthermore,
3D-GMSCs-EVs
derived
from
not
only
had
better
tissue
uptake
capabilities
reduced
bleeding
mice
improved
motor
function.
Subsequent
on
found
hypoxia-preconditioned
promoted
reduction
neuronal
oxidative
stress
levels
mitochondrial
function
recovery.
This
study
innovated
culture
method
GMSCs,
demonstrated
effective
modification
EVs,
provided
ideas
for
establishing
cell-free
hemorrhage.
Journal of Nanobiotechnology,
Journal Year:
2021,
Volume and Issue:
19(1)
Published: Nov. 21, 2021
Mesenchymal
stem
cells
(MSCs)
play
important
roles
in
tissue
repair
and
regeneration,
such
as
the
induction
of
angiogenesis,
particularly
under
hypoxic
conditions.
However,
molecular
mechanisms
underlying
MSC
activation
remain
largely
unknown.
MSC-derived
extracellular
vesicles
(EVs)
are
vital
mediators
cell-to-cell
communication
can
be
directly
utilized
therapeutic
agents
for
regeneration.
Here,
we
explored
effects
EVs
from
human
olfactory
mucosa
MSCs
(OM-MSCs)
on
angiogenesis
its
mechanism.
were
isolated
normoxic
(N)
OM-MSCs
(N-EVs)
(H)
(H-EVs)
using
differential
centrifugation
identified
by
transmission
electron
microscopy
flow
cytometry.
In
vitro
vivo,
both
types
OM-MSC-EVs
promoted
proliferation,
migration,
angiogenic
activities
brain
microvascular
endothelial
(HBMECs).
addition,
angiogenesis-stimulatory
activity
H-EV
group
was
significantly
enhanced
compared
to
N-EV
group.
MicroRNA
profiling
revealed
a
higher
abundance
miR-612
H-EVs
than
N-EVs,
while
inactivation
abolished
treatment
benefit.
To
explore
miR-612,
overexpression
knock-down
experiments
performed
mimic
inhibitor
or
agomir
antagomir
miR-612.
The
target
genes
confirmed
luciferase
reporter
assay.
Gain-
loss-of-function
studies
allowed
validation
(enriched
OM-MSC-EVs)
functional
messenger
that
stimulates
represses
expression
TP53
targeting
3'-untranslated
region.
Further
assays
showed
promote
paracrine
Hypoxia-inducible
factor
1-alpha
(HIF-1α)-Vascular
growth
(VEGF)
signaling
HBMECs
via
exosomal
miR-612-TP53-HIF-1α-VEGF
axis.
These
findings
suggest
may
represent
promising
strategy
ischemic
disease
promoting
transfer.
Frontiers in Neuroscience,
Journal Year:
2021,
Volume and Issue:
15
Published: Feb. 26, 2021
Ischemic
stroke
is
a
leading
cause
of
death
worldwide;
currently
available
treatment
approaches
for
ischemic
are
to
restore
blood
flow,
which
reduce
disability
but
time
limited.
The
interruption
flow
in
contributes
intricate
pathophysiological
processes.
Oxidative
stress
and
inflammatory
activity
two
early
events
the
cascade
cerebral
injury.
These
factors
reciprocal
causation
directly
trigger
development
autophagy.
Appropriate
autophagy
brain
recovery
by
reducing
oxidative
activity,
while
dysfunction
aggravates
Abundant
evidence
demonstrates
beneficial
impact
mesenchymal
stem
cells
(MSCs)
secretome
on
MSCs
through
suppressing
reactive
oxygen
species
(ROS)
nitrogen
(RNS)
generation
transferring
healthy
mitochondria
damaged
cells.
Meanwhile,
exert
anti-inflammation
properties
production
cytokines
extracellular
vesicles,
inhibiting
proinflammatory
activation,
pyroptosis,
alleviating
blood–brain
barrier
leakage.
Additionally,
regulation
imbalances
gives
rise
neuroprotection
against
Altogether,
have
been
promising
candidate
due
their
pleiotropic
effect.
Stem Cell Research & Therapy,
Journal Year:
2021,
Volume and Issue:
12(1)
Published: July 22, 2021
Abstract
Background
Intracerebral
hemorrhage
(ICH)
is
a
major
public
health
concern,
and
mesenchymal
stem
cells
(MSCs)
hold
great
potential
for
treating
ICH.
However,
the
quantity
quality
of
MSCs
decline
in
cerebral
niche,
limiting
efficacy
MSCs.
Hypoxic
preconditioning
suggested
to
enhance
survival
augment
therapeutic
MicroRNAs
(miRNAs)
are
known
mediate
cellular
senescence.
precise
mechanism
by
which
miRNAs
regulate
senescence
hypoxic
remains
be
further
studied.
In
present
study,
we
evaluated
whether
enhances
effects
olfactory
mucosa
MSC
(OM-MSC)
ICH
investigated
mechanisms
miRNA
ameliorates
OM-MSC
Methods
vivo
model,
was
induced
mice
administration
collagenase
IV.
At
24
h
post-ICH,
5
×
10
normoxia
or
hypoxia
OM-MSCs
saline
administered
intracerebrally.
The
behavioral
outcome,
neuronal
apoptosis,
were
evaluated.
vitro
exposed
hemin.
Cellular
examined
evaluating
expressions
P16INK4A,
P21,
P53,
β-galactosidase
staining.
Microarray
bioinformatic
analyses
performed
investigate
differences
expression
profiles
between
OM-MSCs.
Autophagy
confirmed
using
protein
levels
LC3,
P62,
Beclin-1.
Results
transplanted
with
exhibited
increased
tissue-protective
capability.
decreased
Bioinformatic
analysis
identified
that
microRNA-326
(miR-326)
significantly
compared
Upregulation
miR-326
alleviated
senescence,
whereas
downregulation
Furthermore,
showed
upregulating
autophagy.
Mechanistically,
promoted
autophagy
via
PI3K
signaling
pathway
targeting
polypyrimidine
tract-binding
1
(PTBP1).
Conclusions
Our
study
shows
delays
augments
miR-326/PTBP1/PI3K-mediated
International Journal of Molecular Medicine,
Journal Year:
2022,
Volume and Issue:
49(6)
Published: April 7, 2022
Post‑ischemic
neuroinflammation
induced
by
the
innate
local
immune
response
is
a
major
pathophysiological
feature
of
cerebral
ischemic
stroke,
which
remains
leading
cause
mortality
and
disability
worldwide.
NLR
family
pyrin
domain
containing
(NLRP)3
inflammasome
crucially
mediates
post‑ischemic
inflammatory
responses
via
its
priming,
activation
interleukin‑1β
release
during
hypoxic‑ischemic
brain
damage.
Mitochondrial
dysfunctions
are
among
main
hallmarks
several
diseases,
including
stroke.
In
present
review,
focus
was
addressed
on
role
mitochondria
in
stroke
while
keeping
NLRP3
as
link.
Under
ischemia
hypoxia,
capable
controlling
inflammasome‑mediated
through
mitochondrial
released
contents,
localization
related
proteins.
Thus,
may
be
attractive
targets
to
treat
well
drugs
that
target
process
function
At
present,
certain
have
already
been
studied
clinical
trials.
Oxidative Medicine and Cellular Longevity,
Journal Year:
2022,
Volume and Issue:
2022, P. 1 - 11
Published: June 15, 2022
Traumatic
brain
injury
(TBI)
makes
up
a
large
proportion
of
acute
injuries
and
is
major
cause
disability
globally.
Its
complicated
etiology
pathogenesis
mainly
include
primary
secondary
over
time,
which
can
cognitive
deficits,
physical
disabilities,
mood
changes,
impaired
verbal
communication.
Recently,
mesenchymal
stromal
cell-
(MSC-)
based
therapy
has
shown
significant
therapeutic
potential
to
target
TBI-induced
pathological
processes,
such
as
oxidative
stress,
neuroinflammation,
apoptosis,
mitochondrial
dysfunction.
In
this
review,
we
discuss
the
main
processes
TBI
summarize
underlying
mechanisms
MSC-based
treatment.
We
also
research
progress
in
field
MSC
well
shortcomings
great
shown.
iScience,
Journal Year:
2024,
Volume and Issue:
27(6), P. 109865 - 109865
Published: April 30, 2024
Previous
studies
have
indicated
the
neuroprotective
effect
of
olfactory
mucosa
mesenchymal
stem
cells
(OM-MSCs)
on
brain
injury.
Intracerebral
hemorrhage
(ICH)
models
were
established
in
rats
by
injecting
autologous
blood.
SENP1
expression
was
enhanced
neurons
but
decreased
astrocytes
compared
to
that
OM-MSCs.
Overexpression
promoted
proliferation
and
neuronal
differentiation,
while
inhibiting
astrocytic
differentiation
Conversely,
its
knockdown
had
opposite
effect.
Moreover,
OM-MSCs
reduced
neurological
dysfunction
after
ICH,
could
be
further
overexpression.
In
addition,
mitophagy,
which
might
related
SENP1-mediated
OPTN
deSUMOylation.
Furthermore,
through
mitophagy
mediated
OPTN.
Similar
SENP1,
transfection
remission
OM-MSC
ICH
rats.
OPTN-mediated
improve
deficits
Annals of Translational Medicine,
Journal Year:
2021,
Volume and Issue:
9(17), P. 1362 - 1362
Published: Sept. 1, 2021
Microglia
plays
a
vital
role
in
neuroinflammation,
contributing
to
the
pathogenesis
of
intracerebral
hemorrhage
(ICH)-induced
brain
injury.
Mesenchymal
stem
cells
(MSCs)
hold
great
potential
for
treating
ICH.
We
previously
revealed
that
MSCs
ameliorate
microglial
pyroptosis
caused
by
an
ischemic
stroke.
However,
whether
can
modulate
after
ICH
remains
unknown.
This
study
aimed
investigate
neuroprotective
effects
hypoxia-preconditioned
olfactory
mucosa
(OM-MSCs)
on
and
possible
mechanisms.ICH
was
induced
mice
via
administration
collagenase
IV.
At
6
h
post-ICH,
2-4×105
normoxic/hypoxic
OM-MSCs
or
saline
were
intracerebrally
administered.
To
evaluate
effects,
behavioral
outcome,
apoptosis,
neuronal
injury
measured.
activation
pro-inflammatory
cytokines
applied
detect
neuroinflammation.
Microglial
determined
western
blotting,
immunofluorescence
staining,
transmission
electron
microscopy
(TEM).The
two
OM-MSC-transplanted
groups
exhibited
significantly
improved
functional
recovery
reduced
injury,
especially
hypoxic
group.
Hypoxic
attenuated
as
well
levels
interleukin-1β
(IL-1β)
tumor
necrosis
factor-α
(TNF-α).
Moreover,
we
found
ameliorated
diminishing
pyroptosis-associated
proteins
peri-hematoma
tissues,
decreasing
expression
nod-like
receptor
family
protein
3
(NLRP3)
caspase-1,
reducing
membrane
pores
microglia
post-ICH.Our
showed
preconditioning
augments
therapeutic
efficacy
OM-MSCs,
alleviate
model.